Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade

MLA

Jacqueline Niewolik, et al. “Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.” Oncology, vol. 100, Jan. 2022, pp. 392–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119e5be12b522a0455847caa382aebca&authtype=sso&custid=ns315887.

APA

Jacqueline Niewolik, Marie Mikuteit, Anne Cossmann, Kai Vahldiek, Ralf Gutzmer, Frank Müller, Dominik Schröder, Stephanie Heinemann, Georg M.N. Behrens, Alexandra Dopfer-Jablonka, Sandra Steffens, & Imke Grimmelmann. (2022). Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade. Oncology, 100, 392–398.

Chicago

Jacqueline Niewolik, Marie Mikuteit, Anne Cossmann, Kai Vahldiek, Ralf Gutzmer, Frank Müller, Dominik Schröder, et al. 2022. “Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.” Oncology 100 (January): 392–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119e5be12b522a0455847caa382aebca&authtype=sso&custid=ns315887.